After attending this webinar, participants will know:The current scientific basis for the use of non-Vitamin K oral anticoagulants (NOAC)The impact of the different NOACs on laboratory parameters for the assessment of anticoagulationA regimen for “uninterrupted” peri-interventional use of NOACsThe management of peri-interventional bleeding complicationsThe latest on the current status of the antidotes idarucizumab (F.II inhibitors) and andexanet-alfa (F.Xa inhibitors)The current evidence for the use of uninterrupted NOACs in the setting of catheter ablation
Prof. Philipp Sommer (host)
Prof. Richard Schilling (speaker)
Prof. Christian Sticherling (speaker)
Target audience: This webinar addresses EHRA members and cardiologists working in the field of arrhythmias.
During the webinar, you will be able to send your questions by chat and interact with our key opinion leaders who will provide feedback live.
The webinar is available on PC and Tablets. The use of a smartphone is not recommended. For the best viewing experience, a high-speed Internet connection is required (minimum 2Mbps). Please make sure that the firewall does not prevent the connection to the webinar.
European Society of Cardiology
European Heart HouseLes Templiers2035 Route des CollesCS 80179 Biot
06903 Sophia Antipolis, FR
This programme is supported by Boehringer Ingelheim in the form of an unrestricted educational grant.
The scientific programme has not been influenced in any way by its sponsor.
Our mission: To reduce the burden of cardiovascular disease
© 2018 European Society of Cardiology. All rights reserved